Impact of the AI-act on your medical device 

Any medical device that makes use of software, or is a software in itself (MDSW), could potentially fall under the Regulation 2024/1689 (informally known as ‘AI act’), if the software, or part of it, meets the definition as laid down in this Regulation*. For devices falling under the AI Act, the deadline of August 2, 2027, is fast approaching, considering the timelines for conformity assessment.  

This deadline is not only applicable to new AI-enabled medical devices, but also to AI-enabled medical devices undergoing a substantial modification. Unfortunately, it is not yet exactly known what constitutes a substantial modification under the AI Act but note that it is probably different from a substantial change as defined by the MDR.  

Requirements and preparations

Even though the details are not fully known yet, and only one guideline is available, you should not wait to start preparing for the AI Act. The regulation itself already lays down requirements that need to be fulfilled. Part of this overlaps with requirements that are already known from the MDR, but there are also new requirements. For example, requirements on data governance, transparency, human oversight, automatically generated logs, and fundamental rights. 

Interaction with the Notified Body

Furthermore, the interaction with the Notified Body will change somewhat, as the Notified Body can, under the AI Act, request access to datasets, trained models etc. The manufacturer should be able to enable safe and secure remote access through API or other technical means. 

New guidance document

The new guidance document** makes very clear that conformity assessment of AI-enabled medical devices towards MDR and AI Act should be integrated, requiring one single technical documentation, one single quality management system, and as such also one single conformity assessment, which should cover the additional requirements posed by the AI Act. 

Currently, Kiwa is already certifying AI-enabled medical devices under the MDR, and as such has the expertise to evaluate the AI part already, since the MDR also requires accuracy, robustness and reliability as part of the general safety and performance requirements.

At this moment, even though there have so far been no details from the European authorities on how exactly designation will take place, Kiwa is actively working towards getting designated, by extending competences, procedures and testing facilities for AI Act specific requirements. To make sure we will be able to accept your applications or continue with ongoing applications and already MDR certified AI-enabled medical devices, as soon as we are designated to the AI act.  

* See also C(2025) 5053 final, d.d. 29.7.2025; Commission Guidelines on the definition of an artificial intelligence system established by Regulation (EU) 2024/1689 (AI Act) 

** AIB 2025-1 MDCG 2025-6 Interplay between the Medical Devices Regulation (MDR) & In vitro Diagnostic Medical Devices Regulation (IVDR) and the Artificial Intelligence Act (AIA) 

Article

Overview of AI-Enabled SaMD and SiMD Devices

Artificial Intelligence (AI)-based software medical devices are revolutionizing the healthcare sector in diagnosis, treatment, and patient management. AI-powered Software as a Medical Device (SaMD) and Software in a Medical Device (SiMD) applications cover a wide range of solutions, from medical decision support systems to patient monitoring tools.

story

AI Medical Device Software

Recently, the European Parliament adopted the Artificial Intelligence Act: MEPs adopt landmark law. The regulation aims to safeguard fundamental rights, democracy, and environmental sustainability. The new set of rules implies a need for more careful examination of the evidence regarding the continuous safety and performance of AI-driven medical device software.

Contact us

Would you like to know more about our services in the field of Medical devices? Please contact us using this form.